Osgood-Schlatter Disease Clinical Trial
Official title:
A Comparison of Two Different Treatment Approaches for Adolescents With Osgood Schlatter: A Randomized Controlled Superiority Trial (The SOGOOD Trial)
The most common growth-related injury is Osgood Schlatter, which affects up to 1 in 5 physically active adolescents. It can cause long-term pain and potential discontinuation of sports and physical activity, with sequela well into adulthood. No effective conservative treatments have been documented, and clinical practice is characterized by a wealth of conflicting advice and modalities. A novel treatment approach has shown promising results in a small single-cohort study. Therefore, this study aims to compare this novel treatment with usual care in 10-16-year-old adolescents with Osgood Schlatter. This single-center pragmatic, double-blinded, randomized, controlled superiority trial, will have a two-group parallel arm design. Participants will undergo 3 months of treatment, followed by 2 months of self-management with self-reported knee function (KOOS-child 'Sport/rec') at 5 months as the primary endpoint. This trial comparing a novel treatment with usual care for adolescents with Osgood Schlatter could result in an evidence-based treatment ready for implementation in clinical practice, benefitting patients outcomes and clinicians.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04716608 -
Treatment for Osgood Schlatter Patients With a Physiotherapy Program
|
N/A | |
| Completed |
NCT03589001 -
24 Month Follow-up of Patients With Osgood Schlatter (OSD)
|
||
| Recruiting |
NCT05826340 -
Getting Kids With Osgood Schlatter Back to Performing Without Pain
|
N/A | |
| Completed |
NCT01300754 -
Effectiveness of Dextrose Injection for Osgood-Schlatter Disease
|
Phase 1/Phase 2 | |
| Completed |
NCT05789095 -
Rate of Torque Development in Adolescents With Osgood-Schlatter
|